Fortune

Patients First: Transforming Care Through Disruptive Technology

May 26, 2022

Media Coverage

Related content

Tempus Expands Strategic Collaboration with Bristol Myers Squibb

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus to Report Third Quarter 2026 Financial Results on November 2